Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersHospitalist Physician in Chicago, IL
NPI: 1194983981Primary Practice Location
JOHN H STROGER JR HOSPITAL
1969 W Ogden Ave, Chicago, IL
Primary Employer
Cook County Health & Hospitals System Physician Services
cookcountyhealth.org
Looking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
IL State Medical License
IL State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 18 | 63 |
| 2 | 99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 15 | 16 |
| 3 | 99238Hospital discharge day management, 30 minutes or less | 13 | 13 |
Authors: Joyce Wang, Jeffrey Henderson, Bo Fu, Nelson Michael, David Diemert, Lawrence Sher
Journal: EClinicalMedicine
Publication Date: 2023-07-22
Authors: Yaveen Santhiraj, Aniesh Bobba, Nigist Taddese
Journal: Open Forum Infect Dis
Publication Date: 2022-07-22
Lead Sponsor: Sanofi Pasteur, a Sanofi Company
Collaborators: GlaxoSmithKline
Intervention / Treatment: BIOLOGICAL: SARS-CoV-2 adjuvanted recombinant protein vaccine, bivalent (D614+B.1.351)-AS03, BIOLOGICAL: SARS-CoV-2 recombinant protein vaccine Phase 2 Formulation 1, BIOLOGICAL: SARS-CoV-2 recombinant protein vaccine Phase 2 Formulation 2, BIOLOGICAL: SARS-CoV-2 recombinant protein vaccine Phase 2 Formulation 3, BIOLOGICAL: SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (D614)-AS03, Dosage A, BIOLOGICAL: SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (B.1.351)-AS03, BIOLOGICAL: SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (D614)-AS03, Dosage B, BIOLOGICAL: SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (B.1.351)-AS03 Alternative Exploratory Formulation 1, BIOLOGICAL: SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (B.1.351)-AS03 Alternative Exploratory Formulation 2, BIOLOGICAL: SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (B.1.351)-AS03 Alternative Exploratory Formulation 3, BIOLOGICAL: SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (B.1.351)-AS03 Alternative Exploratory Formulation 4
